Overview

A Bioequivalence Study of IMPLANON and Radiopaque IMPLANON (34528)(P05720)

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to demonstrate the bioequivalence of IMPLANON and Radiopaque IMPLANON.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Desogestrel
Etonogestrel